Cash flow Japan Tissue Engineering Co., Ltd.

Stocks

7774

JP3389610001

Medical Equipment, Supplies & Distribution

Market Closed - Japan Exchange Other stock markets 02:30:00 2026-06-11 am EDT			5-day change	1st Jan Change
578.00 ^JPY	-1.87%		-2.69%	-7.07%

Apr. 30	Japan Tissue Engineering Co., Ltd. Reports Earnings Results for the Full Year Ended March 31, 2026	CI
Jan. 30	Japan Tissue Engineering Co., Ltd. Revises Non-Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2026	CI

27c8da87d4f2611d2ae0f9ae1.eKPjMANy0LJM51Sf9KDPsANVG54SLWO-P-TUxV-ivCg.SMGsYEoqhoZ6kB7Ixdj972wjKshXHhrcWKvtkG-UjEYfkLJmNAW_2yiSOw

Published financial data: JAPAN TISSUE ENGINEERING CO., LTD.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2021	2022	2023	2024	2025
Revenues	1.54B	1.71B	1.61B	1.65B	1.72B
Other Revenues, Total	722M	391M	419M	866M	732M
Total Revenues	2.26B	2.1B	2.03B	2.51B	2.46B
Cost of Goods Sold, Total	1.1B	848M	896M	823M	944M
Gross Profit	1.16B	1.26B	1.14B	1.69B	1.51B
Selling General & Admin Expenses, Total	1.08B	1.12B	1.22B	1.06B	1.15B
R&D Expenses	468M	561M	573M	407M	506M
Depreciation & Amortization - (IS)	19M	17M	21M	23M	41M
Other Operating Expenses	52M	52M	49M	59M	55M
Other Operating Expenses, Total	1.62B	1.75B	1.86B	1.55B	1.75B
Operating Income	-467M	-498M	-728M	145M	-238M
Interest And Investment Income	3M	2M	1M	-	2M
Net Interest Expenses	3M	2M	1M	-	2M
Currency Exchange Gains (Loss)	-	-	-1M	-	-
Other Non Operating Income (Expenses)	1M	3M	2M	1M	1M
EBT, Excl. Unusual Items	-463M	-493M	-726M	146M	-235M
Gain (Loss) On Sale Of Assets	-	-1M	-	-	-
Asset Writedown	-	-	-	-130M	-10M
Other Unusual Items	-	-	-	130M	10M
EBT, Incl. Unusual Items	-463M	-494M	-726M	146M	-235M
Income Tax Expense	3M	3M	3M	3M	20M
Earnings From Continuing Operations	-466M	-497M	-729M	143M	-255M
Net Income to Company	-466M	-497M	-729M	143M	-255M
Net Income - (IS)	-466M	-497M	-729M	143M	-255M
Net Income to Common Incl Extra Items	-466M	-497M	-729M	143M	-255M
Net Income to Common Excl. Extra Items	-466M	-497M	-729M	143M	-255M
Per Share Items
Net EPS - Basic	-11.48	-12.24	-17.95	3.52	-6.28
Basic EPS - Continuing Operations	-11.48	-12.24	-17.95	3.52	-6.28
Basic Weighted Average Shares Outstanding	40.61M	40.61M	40.61M	40.61M	40.61M
Net EPS - Diluted	-11.48	-12.24	-17.95	3.52	-6.28
Diluted EPS - Continuing Operations	-11.48	-12.24	-17.95	3.52	-6.28
Diluted Weighted Average Shares Outstanding	40.61M	40.61M	40.61M	40.61M	40.61M
Normalized Basic EPS	-7.13	-7.59	-11.17	2.25	-3.62
Normalized Diluted EPS	-7.13	-7.59	-11.17	2.25	-3.62
Supplemental Items
EBITDA	-339M	-374M	-597M	279M	-80M
EBITA	-467M	-498M	-728M	145M	-238M
EBIT	-467M	-498M	-728M	145M	-238M
EBITDAR	-314M	-357M	-582M	294M	-64M
Effective Tax Rate - (Ratio)	-0.65	-0.61	-0.41	2.05	-8.51
Normalized Net Income	-289M	-308M	-454M	91.25M	-147M
Non-Cash Pension Expense	11M	11M	12M	12M	21M
Supplemental Operating Expense Items
General and Administrative Expenses	68M	61M	56M	51M	52M
Research And Development Expense From Footnotes	468M	561M	573M	407M	506M
Net Rental Expense, Total	25M	17M	15M	15M	16M

Fiscal Period: March	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	5.28B	4.93B	4.13B	4.27B	3.88B
Total Cash And Short Term Investments	5.28B	4.93B	4.13B	4.27B	3.88B
Accounts Receivable, Total	822M	496M	576M	608M	594M
Total Receivables	822M	496M	576M	608M	594M
Inventory	204M	187M	237M	228M	181M
Prepaid Expenses	5M	18M	21M	32M	30M
Deferred Tax Assets Current	-	-	-	-	-
Other Current Assets, Total	238M	311M	243M	205M	134M
Total Current Assets	6.54B	5.94B	5.21B	5.34B	4.82B
Net Property Plant And Equipment	1.56B	1.61B	1.57B	1.51B	1.42B
Long-term Investments	2M	2M	10M	36M	171M
Other Intangibles, Total	16M	36M	93M	102M	96M
Deferred Tax Assets Long-Term	-	-	-	-	-
Deferred Charges Long-Term	-	-	-	-	-
Other Long-Term Assets, Total	2M	2M	2M	1M	1M
Total Assets	8.12B	7.6B	6.88B	6.99B	6.51B
Liabilities
Accounts Payable, Total	148M	117M	136M	84M	109M
Accrued Expenses, Total	159M	151M	151M	180M	151M
Current Portion of Leases	-	-	-	-	-
Current Income Taxes Payable	351M	301M	337M	245M	208M
Other Current Liabilities	261M	327M	287M	364M	169M
Total Current Liabilities	919M	896M	911M	873M	637M
Long-Term Leases	-	-	-	-	-
Pension & Other Post Retirement Benefits	34M	34M	34M	34M	50M
Other Non Current Liabilities	2M	2M	1M	1M	-
Total Liabilities	955M	932M	946M	908M	687M
Common Stock, Total	4.96B	4.96B	4.96B	4.96B	4.96B
Additional Paid In Capital	2.79B	2.79B	2.79B	2.79B	2.79B
Retained Earnings	-582M	-1.08B	-1.81B	-1.67B	-1.92B
Comprehensive Income and Other	-	-	1M	-	1M
Total Common Equity	7.16B	6.67B	5.94B	6.08B	5.82B
Total Equity	7.16B	6.67B	5.94B	6.08B	5.82B
Total Liabilities And Equity	8.12B	7.6B	6.88B	6.99B	6.51B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	40.61M	40.61M	40.61M	40.61M	40.61M
ECS Total Common Shares Outstanding	40.61M	40.61M	40.61M	40.61M	-
Book Value / Share	176.41	164.15	146.2	149.72	143.44
Tangible Book Value	7.15B	6.63B	5.84B	5.98B	5.73B
Tangible Book Value Per Share	176.02	163.26	143.91	147.21	141.07
Total Debt	0	0	0	0	0
Net Debt	-5.28B	-4.93B	-4.13B	-4.27B	-3.88B
Debt Equivalent of Unfunded Proj. Benefit Obligation	-	-	-	-	4M
Debt Equivalent Oper. Leases	200M	136M	120M	120M	128M
Inventories - Raw Materials, Total	188M	158M	206M	172M	162M
Inventories - Work In Process, Total	12M	28M	30M	55M	17M
Inventories - Finished Goods, Total	3M	-	-	-	1M
Inventories - Others	1M	1M	1M	1M	1M
Full Time Employees	200	207	215	211	204
Order Backlog	185M	184M	224M	401M	245M

Fiscal Period: March	2021	2022	2023	2024	2025
Net Income	-462M	-494M	-725M	147M	-234M
Depreciation & Amortization - CF	128M	124M	131M	134M	158M
Depreciation & Amortization, Total	128M	124M	131M	134M	158M
(Gain) Loss From Sale Of Asset	-	-	-	130M	10M
Other Operating Activities, Total	-2M	-1M	-2M	-3M	-27M
Change In Accounts Receivable	-140M	325M	-79M	-32M	14M
Change In Inventories	-38M	16M	-50M	9M	46M
Change In Accounts Payable	90M	-114M	14M	-23M	-4M
Change in Other Net Operating Assets	25M	-81M	89M	-88M	-111M
Cash from Operations	-399M	-225M	-622M	274M	-148M
Capital Expenditure	-62M	-103M	-149M	-196M	-76M
Sale (Purchase) of Intangible assets	-12M	-14M	-26M	-77M	-17M
Investment in Marketable and Equity Securities, Total	200M	-	1.3B	-100M	-150M
Other Investing Activities, Total	-1M	1M	-1M	131M	11M
Cash from Investing	125M	-116M	1.12B	-242M	-232M
Issuance of Common Stock	-	-	-	-	-
Other Financing Activities, Total	-1M	-	-	-	-
Cash from Financing	-1M	-	-	-	-
Miscellaneous Cash Flow Adjustments	-	-1M	-1M	-1M	-
Net Change in Cash	-275M	-342M	501M	31M	-380M
Supplemental Items
Cash Income Tax Paid (Refund)	3M	3M	3M	3M	27M
Levered Free Cash Flow	-304M	-70.25M	-549M	-82.38M	-186M
Unlevered Free Cash Flow	-304M	-70.25M	-549M	-82.38M	-186M
Change In Net Working Capital	66M	-234M	50M	34M	102M

Fiscal Period: March	2021	2022	2023	2024	2025
Profitability
Return on Assets	-3.52	-3.96	-6.28	1.31	-2.2
Return on Total Capital	-3.94	-4.5	-7.22	1.51	-2.5
Return On Equity %	-6.3	-7.19	-11.57	2.38	-4.28
Return on Common Equity	-6.3	-7.19	-11.57	2.38	-4.28
Margin Analysis
Gross Profit Margin %	51.22	59.68	55.91	67.26	61.55
SG&A Margin	48.03	53.4	60.09	42.04	46.72
EBITDA Margin %	-15.02	-17.78	-29.38	11.1	-3.26
EBITA Margin %	-20.69	-23.68	-35.83	5.77	-9.69
EBIT Margin %	-20.69	-23.68	-35.83	5.77	-9.69
Income From Continuing Operations Margin %	-20.65	-23.63	-35.88	5.69	-10.39
Net Income Margin %	-20.65	-23.63	-35.88	5.69	-10.39
Net Avail. For Common Margin %	-20.65	-23.63	-35.88	5.69	-10.39
Normalized Net Income Margin	-12.82	-14.65	-22.33	3.63	-5.98
Levered Free Cash Flow Margin	-13.46	-3.34	-27.02	-3.28	-7.57
Unlevered Free Cash Flow Margin	-13.46	-3.34	-27.02	-3.28	-7.57
Asset Turnover
Asset Turnover	0.27	0.27	0.28	0.36	0.36
Fixed Assets Turnover	1.42	1.33	1.28	1.63	1.68
Receivables Turnover (Average Receivables)	2.04	2.6	3.01	2.78	2.87
Inventory Turnover (Average Inventory)	5.95	4.34	4.23	3.54	4.62
Short Term Liquidity
Current Ratio	7.12	6.64	5.72	6.12	7.57
Quick Ratio	6.63	6.06	5.17	5.58	7.03
Operating Cash Flow to Current Liabilities	-0.43	-0.25	-0.68	0.31	-0.23
Days Sales Outstanding (Average Receivables)	178.7	140.5	121.29	131.48	127.32
Days Outstanding Inventory (Average Inventory)	61.33	84.15	86.36	103.4	79.07
Average Days Payable Outstanding	42.78	58.2	48.81	49.46	39.27
Cash Conversion Cycle (Average Days)	197.24	166.45	158.84	185.41	167.12
Long Term Solvency
Total Debt/Equity	-	-	-	-	-
Total Debt / Total Capital	-	-	-	-	-
LT Debt/Equity	-	-	-	-	-
Long-Term Debt / Total Capital	-	-	-	-	-
Total Liabilities / Total Assets	11.76	12.27	13.74	12.99	10.55
Total Debt / EBITDA	-	-	-	-	-
Net Debt / EBITDA	15.56	13.19	6.92	-15.29	48.56
Total Debt / (EBITDA - Capex)	-	-	-	-	-
Net Debt / (EBITDA - Capex)	13.15	10.34	5.54	-51.4	24.9
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-2.25	-6.82	-3.38	23.72	-2.35
Gross Profit, 1 Yr. Growth %	-2.61	8.56	-9.48	48.86	-10.64
EBITDA, 1 Yr. Growth %	202.68	10.32	59.63	-146.73	-128.67
EBITA, 1 Yr. Growth %	97.88	6.64	46.18	-119.92	-264.14
EBIT, 1 Yr. Growth %	97.88	6.64	46.18	-119.92	-264.14
Earnings From Cont. Operations, 1 Yr. Growth %	62.37	6.65	46.68	-119.62	-278.32
Net Income, 1 Yr. Growth %	62.37	6.65	46.68	-119.62	-278.32
Normalized Net Income, 1 Yr. Growth %	101.3	6.48	47.26	-120.11	-260.96
Diluted EPS Before Extra, 1 Yr. Growth %	62.37	6.65	46.68	-119.62	-278.32
Accounts Receivable, 1 Yr. Growth %	20.7	-39.66	16.13	5.56	-2.3
Inventory, 1 Yr. Growth %	22.89	-8.33	26.74	-3.8	-20.61
Net Property, Plant and Equip., 1 Yr. Growth %	-4.07	3.73	-2.85	-3.64	-5.96
Total Assets, 1 Yr. Growth %	-3.93	-6.42	-9.41	1.53	-6.81
Tangible Book Value, 1 Yr. Growth %	-6.21	-7.25	-11.86	2.29	-4.17
Common Equity, 1 Yr. Growth %	-6.12	-6.95	-10.94	2.41	-4.19
Cash From Operations, 1 Yr. Growth %	375	-43.61	176.44	-144.05	-154.01
Capital Expenditures, 1 Yr. Growth %	-28.74	66.13	44.66	31.54	-61.22
Levered Free Cash Flow, 1 Yr. Growth %	218.19	-76.88	681.49	-85	125.49
Unlevered Free Cash Flow, 1 Yr. Growth %	218.19	-76.88	681.49	-85	125.49
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-2.14	-4.56	-5.12	9.34	9.92
Gross Profit, 2 Yr. CAGR %	-5.12	2.82	-0.87	16.08	15.33
EBITDA, 2 Yr. CAGR %	21.14	82.74	32.7	-13.63	-63.39
EBITA, 2 Yr. CAGR %	15.51	45.26	24.86	-46.04	-42.82
EBIT, 2 Yr. CAGR %	15.51	45.26	24.86	-46.04	-42.82
Earnings From Cont. Operations, 2 Yr. CAGR %	18.3	31.59	25.08	-46.36	-40.86
Net Income, 2 Yr. CAGR %	18.3	31.59	25.08	-46.36	-40.86
Normalized Net Income, 2 Yr. CAGR %	16.87	46.41	25.22	-45.58	-43.11
Diluted EPS Before Extra, 2 Yr. CAGR %	18.3	31.59	25.08	-46.36	-40.86
Accounts Receivable, 2 Yr. CAGR %	5.9	-14.66	-16.29	10.72	1.55
Inventory, 2 Yr. CAGR %	18.21	6.14	7.79	10.42	-12.61
Net Property, Plant and Equip., 2 Yr. CAGR %	-2.95	-0.25	0.39	-3.25	-4.81
Total Assets, 2 Yr. CAGR %	-3.68	-5.18	-7.93	-4.1	-2.73
Tangible Book Value, 2 Yr. CAGR %	-4.88	-6.73	-9.58	-5.04	-0.99
Common Equity, 2 Yr. CAGR %	-4.88	-6.54	-8.97	-4.5	-0.95
Cash From Operations, 2 Yr. CAGR %	0.38	63.66	24.86	10.35	-51.22
Capital Expenditures, 2 Yr. CAGR %	-4.51	8.81	55.02	37.95	-28.58
Levered Free Cash Flow, 2 Yr. CAGR %	6.73	-14.23	34.41	8.29	-41.83
Unlevered Free Cash Flow, 2 Yr. CAGR %	6.73	-14.23	34.41	8.29	-41.83
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-0.21	-3.73	-4.17	3.66	5.29
Gross Profit, 3 Yr. CAGR %	-5.11	-0.76	-1.45	13.52	6.38
EBITDA, 3 Yr. CAGR %	1.11	17.42	74.68	-6.29	-40.19
EBITA, 3 Yr. CAGR %	30.11	12.47	45.57	-32.29	-21.82
EBIT, 3 Yr. CAGR %	30.11	12.47	45.57	-32.29	-21.82
Earnings From Cont. Operations, 3 Yr. CAGR %	27.09	14.28	36.44	-32.55	-19.94
Net Income, 3 Yr. CAGR %	27.09	14.28	36.44	-32.55	-19.94
Normalized Net Income, 3 Yr. CAGR %	29.54	13.3	46.69	-31.94	-21.88
Diluted EPS Before Extra, 3 Yr. CAGR %	27.09	14.28	36.44	-32.55	-19.94
Accounts Receivable, 3 Yr. CAGR %	11.62	-12.21	-5.43	-9.56	6.19
Inventory, 3 Yr. CAGR %	14.75	8.6	12.6	3.78	-1.08
Net Property, Plant and Equip., 3 Yr. CAGR %	-2.08	-0.77	-1.12	-0.97	-4.16
Total Assets, 3 Yr. CAGR %	-3.46	-4.6	-6.61	-4.88	-5.01
Tangible Book Value, 3 Yr. CAGR %	-4.58	-5.67	-8.47	-5.78	-4.75
Common Equity, 3 Yr. CAGR %	-4.6	-5.58	-8.03	-5.32	-4.4
Cash From Operations, 3 Yr. CAGR %	-14.21	-17.17	94.91	-11.77	-13.03
Capital Expenditures, 3 Yr. CAGR %	25.99	14.84	19.64	46.76	-9.64
Levered Free Cash Flow, 3 Yr. CAGR %	-15.21	-35.9	79.14	-35.28	38.28
Unlevered Free Cash Flow, 3 Yr. CAGR %	-15.21	-35.9	79.14	-35.28	38.28
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	9.56	-0.3	-2.2	1.3	1.23
Gross Profit, 5 Yr. CAGR %	14.87	0.5	-3.44	5.66	4.95
EBITDA, 5 Yr. CAGR %	-10.4	-2.52	12.72	3.85	-6.51
EBITA, 5 Yr. CAGR %	-8.37	9.73	27.98	-16.16	0.17
EBIT, 5 Yr. CAGR %	-8.37	9.73	27.98	-16.16	0.17
Earnings From Cont. Operations, 5 Yr. CAGR %	-7.31	12.48	26.28	-15.55	-2.34
Net Income, 5 Yr. CAGR %	-7.31	12.48	26.28	-15.55	-2.34
Normalized Net Income, 5 Yr. CAGR %	-7.34	9.79	27.79	-15.51	0.43
Diluted EPS Before Extra, 5 Yr. CAGR %	-7.32	12.47	26.28	-15.55	-2.34
Accounts Receivable, 5 Yr. CAGR %	12.61	-9.85	-0.51	-3.67	-2.7
Inventory, 5 Yr. CAGR %	10.65	12.24	11.91	9.32	1.75
Net Property, Plant and Equip., 5 Yr. CAGR %	-3.11	-1.33	-1.1	-1.77	-2.61
Total Assets, 5 Yr. CAGR %	-0.43	-2.32	-5.27	-4.4	-5.08
Tangible Book Value, 5 Yr. CAGR %	-1.4	-3.61	-6.61	-5.42	-5.55
Common Equity, 5 Yr. CAGR %	-1.48	-3.59	-6.37	-5.15	-5.26
Cash From Operations, 5 Yr. CAGR %	2.89	33.03	-0.32	-7.1	11.99
Capital Expenditures, 5 Yr. CAGR %	-24.69	66.71	36.89	23.58	-2.67
Levered Free Cash Flow, 5 Yr. CAGR %	-4.06	12.28	1.95	-20.94	14.23
Unlevered Free Cash Flow, 5 Yr. CAGR %	-4.06	12.28	1.95	-20.94	14.23